NCT04858516 2021-04-26
Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer
Guangdong Provincial People's Hospital
Phase 2 Unknown
Clinical Trials
1 trialsUnknown × Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer × palbociclib × Clear all